Ohr Pharmaceutical Inc (OHRP)

Add to Watchlists
Create an Alert
2.11 -0.02  -0.94% NASDAQ Feb 15, 20:00 Delayed 2m USD
View Full Chart
OHRP Price Chart
View All Events

OHRP Events

Date Type Description
02/04/2019 Splits Ratio: 1:20
View All Performance Charts

OHRP Total Returns Comparison

Advertisement

OHRP One Page Reports

Edit

Profile

  • URL: http://www.ohrpharmaceutical.com
  • Investor Relations URL: http://ir.ohrpharmaceutical.com/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Feb. 14, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The lead product of the company is topical Squalamine is a novel therapeutic product which provides non-invasive therapy to improve visual outcomes. Its product pipeline includes SQUALAMINE LACTATE OPHTHALMIC SOLUTION 0.2%, SKS sustained release ocular drug delivery platform technology, Animal Model for Dry-AMD, and Non-Ophthalmology Assets.

OHRP Comparables

Edit

OHRP Excel Add-In Codes

  • Name: =YCI("OHRP","name")
  • Description: =YCI("OHRP","description")
  • Sector: =YCI("OHRP","sector")
  • Industry: =YCI("OHRP","industry")
  • Est. Current Fiscal Year End: =YCI("OHRP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.